(BRZE) Braze - Ratings and Ratios
Platform, SDKs, APIs, Analytics, Orchestration
BRZE EPS (Earnings per Share)
BRZE Revenue
Description: BRZE Braze August 03, 2025
Braze Inc. (NASDAQ:BRZE) is a customer engagement platform that enables brands to interact with consumers through various channels. The companys platform provides a range of tools, including software development kits, REST API, and data integrations, to help brands manage customer data and create personalized marketing experiences.
Key features of Brazes platform include classification products, such as segmentation, segment insights, and predictive suite, which allow brands to identify and target high-value customer segments. The company also offers Canvas, an orchestration tool that enables brands to create multi-step, cross-channel marketing campaigns, as well as personalization products, such as liquid templating and AI-powered item recommendations.
From a financial perspective, Braze has a market capitalization of $3.145 billion and a forward P/E ratio of 166.67, indicating high growth expectations. However, the companys return on equity (RoE) is currently negative at -22.33%, suggesting that it is still in a growth phase and investing heavily in its business. Other key performance indicators (KPIs) to watch include revenue growth, customer acquisition costs, and customer lifetime value.
To evaluate Brazes stock, we can look at additional KPIs such as revenue growth rate, gross margin, operating expenses as a percentage of revenue, and customer retention rate. For example, if Brazes revenue growth rate is high and its gross margin is expanding, it could be a positive sign. On the other hand, if customer acquisition costs are rising faster than revenue, it could be a concern. By analyzing these KPIs, we can gain a deeper understanding of Brazes business performance and make more informed investment decisions.
BRZE Stock Overview
| Market Cap in USD | 3,063m |
| Sub-Industry | Application Software |
| IPO / Inception | 2021-11-17 |
BRZE Stock Ratings
| Growth Rating | -25.5% |
| Fundamental | 45.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -26.7% |
| Analyst Rating | 4.50 of 5 |
BRZE Dividends
Currently no dividends paidBRZE Growth Ratios
| Growth Correlation 3m | 31.8% |
| Growth Correlation 12m | -78.9% |
| Growth Correlation 5y | -30.2% |
| CAGR 5y | 6.39% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.11 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.25 |
| Sharpe Ratio 12m | 0.14 |
| Alpha | -33.08 |
| Beta | 1.103 |
| Volatility | 47.87% |
| Current Volume | 1765.4k |
| Average Volume 20d | 1330.8k |
| Stop Loss | 26.4 (-6%) |
| Signal | 0.03 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (-108.8m TTM) > 0 and > 6% of Revenue (6% = 39.3m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 1.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.99% (prev 57.54%; Δ -37.56pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 36.8m > Net Income -108.8m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.37 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (106.8m) change vs 12m ago 5.28% (target <= -2.0% for YES) |
| Gross Margin 68.79% (prev 68.77%; Δ 0.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 70.84% (prev 64.91%; Δ 5.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -7.81 (EBITDA TTM -116.6m / Interest Expense TTM -16.5m) >= 6 (WARN >= 3) |
Altman Z'' -3.79
| (A) 0.13 = (Total Current Assets 484.5m - Total Current Liabilities 353.7m) / Total Assets 1.02b |
| (B) -0.64 = Retained Earnings (Balance) -650.5m / Total Assets 1.02b |
| (C) -0.14 = EBIT TTM -129.1m / Avg Total Assets 924.1m |
| (D) -1.54 = Book Value of Equity -650.6m / Total Liabilities 423.5m |
| Total Rating: -3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.60
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 1.05% = 0.52 |
| 3. FCF Margin 4.46% = 1.12 |
| 4. Debt/Equity 0.14 = 2.49 |
| 5. Debt/Ebitda -0.03 = -2.50 |
| 6. ROIC - WACC (= -30.46)% = -12.50 |
| 7. RoE -21.69% = -2.50 |
| 8. Rev. Trend 99.20% = 7.44 |
| 9. EPS Trend 30.51% = 1.53 |
What is the price of BRZE shares?
Over the past week, the price has changed by +3.46%, over one month by -3.01%, over three months by +4.08% and over the past year by -12.84%.
Is Braze a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BRZE is around 24.06 USD . This means that BRZE is currently overvalued and has a potential downside of -14.32%.
Is BRZE a buy, sell or hold?
- Strong Buy: 11
- Buy: 8
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BRZE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.8 | 59.7% |
| Analysts Target Price | 44.8 | 59.7% |
| ValueRay Target Price | 27.2 | -3.2% |
BRZE Fundamental Data Overview November 01, 2025
P/E Forward = 46.9484
P/S = 4.6793
P/B = 5.1539
P/EG = 1.5672
Beta = 1.103
Revenue TTM = 654.6m USD
EBIT TTM = -129.1m USD
EBITDA TTM = -116.6m USD
Long Term Debt = 84.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 84.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.44m USD (from netDebt column, last quarter)
Enterprise Value = 2.78b USD (3.06b + Debt 84.4m - CCE 363.6m)
Interest Coverage Ratio = -7.81 (Ebit TTM -129.1m / Interest Expense TTM -16.5m)
FCF Yield = 1.05% (FCF TTM 29.2m / Enterprise Value 2.78b)
FCF Margin = 4.46% (FCF TTM 29.2m / Revenue TTM 654.6m)
Net Margin = -16.62% (Net Income TTM -108.8m / Revenue TTM 654.6m)
Gross Margin = 68.79% ((Revenue TTM 654.6m - Cost of Revenue TTM 204.3m) / Revenue TTM)
Gross Margin QoQ = 67.67% (prev 68.62%)
Tobins Q-Ratio = 2.72 (Enterprise Value 2.78b / Total Assets 1.02b)
Interest Expense / Debt = 4.54% (Interest Expense 3.83m / Debt 84.4m)
Taxrate = 20.15% (-7.01m / -34.8m)
NOPAT = -103.1m (EBIT -129.1m * (1 - 20.15%)) [loss with tax shield]
Current Ratio = 1.37 (Total Current Assets 484.5m / Total Current Liabilities 353.7m)
Debt / Equity = 0.14 (Debt 84.4m / totalStockholderEquity, last quarter 598.9m)
Debt / EBITDA = -0.03 (negative EBITDA) (Net Debt 3.44m / EBITDA -116.6m)
Debt / FCF = 0.12 (Net Debt 3.44m / FCF TTM 29.2m)
Total Stockholder Equity = 501.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.64% (Net Income -108.8m / Total Assets 1.02b)
RoE = -21.69% (Net Income TTM -108.8m / Total Stockholder Equity 501.6m)
RoCE = -22.04% (EBIT -129.1m / Capital Employed (Equity 501.6m + L.T.Debt 84.4m))
RoIC = -20.56% (negative operating profit) (NOPAT -103.1m / Invested Capital 501.6m)
WACC = 9.91% (E(3.06b)/V(3.15b) * Re(10.08%) + D(84.4m)/V(3.15b) * Rd(4.54%) * (1-Tc(0.20)))
Discount Rate = 10.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.46%
[DCF Debug] Terminal Value 61.85% ; FCFE base≈21.2m ; Y1≈13.9m ; Y5≈6.37m
Fair Price DCF = 0.94 (DCF Value 92.7m / Shares Outstanding 99.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 30.51 | EPS CAGR: 20.67% | SUE: -0.36 | # QB: 0
Revenue Correlation: 99.20 | Revenue CAGR: 27.11% | SUE: 4.0 | # QB: 9
Additional Sources for BRZE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle